What Manna Molecular does

Manna Molecular Science, LLC is a privately held, Massachusetts-incorporated cannabis and CBD product company that develops science-led drug-delivery formats rather than commoditized flower or edibles. Its proprietary nano-encapsulation and liposomal technology underpins a small product portfolio: the Manna Patch (an 8–10 hour transdermal THC/CBD patch with 30–90 minute onset), Manna SpeedTabs (a 5mg sublingual tablet with 3–5 minute onset and 60-minute offset), Vella (a cannabinoid-based intimate serum for female arousal using nano-encapsulated CBD to target vaginal smooth muscle), and BevPow (a nano-liposomal cannabis drink mix in development). Allergen-free, vegan, and gluten-free formulations are positioned for both medical and recreational consumers.

The company makes money primarily through wholesale sales of these branded products to licensed cannabis dispensaries. The Manna Patch is currently sold across roughly 11 U.S. states — Massachusetts, Maine, New Hampshire, Pennsylvania, Ohio, Florida, Colorado, Utah, Nevada, California, and Alaska — with more than 40 dispensary relationships in Massachusetts alone, while SpeedTabs remains Massachusetts-only. A direct-to-consumer e-commerce channel for CBD and CBN products is in build-out, with the website currently displaying 'online sales coming soon,' signaling a planned shift from wholesale-only to an omnichannel model. Customer segments include medical cannabis patients (chronic pain, injury recovery), recreational consumers seeking precise dosing, CBD/wellness users, and women's sexual health consumers via Vella.

Manna is led by CEO and co-founder Nial C. DeMena, CSO Michael Frid (PhD, MIT Organic Chemistry), CMO Harin Padma-Nathan, CFO Frank Manganella, and CDO Carolyn Wheeler. The company pursues a content-first, education-driven marketing approach via its Lab Notes blog, Instagram, and email newsletter, and participates in industry events such as MJBizCon to build brand credibility. No funding rounds, revenue figures, patents, or institutional investors are disclosed in the available source material.

Name

Manna Molecular

Legal name

Manna Molecular Science, LLC

Website

https://mannamolecular.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Manna Molecular is a privately held Massachusetts cannabis company that develops science-led transdermal, sublingual, and beverage cannabinoid products (Manna Patch, SpeedTabs, Vella, BevPow) using proprietary nano-encapsulation, sold through dispensaries in 11 U.S. states.

Ownership category

akta.pro rank

Product category

Cannabis & CBD Consumer Products

NAICS

Medicinal and Botanical Manufacturing (325411)

akta.pro primary industry

Cannabis Accessories & Ancillary Product Delivery (Vapes, Papers, Devices) (CRANAGAJ)

akta.pro secondary industry

Cannabis Accessories & Ancillary Products Wholesale (Vapes, Packaging, Hardware) (CRAOAIAH)

Keywords

• Transdermal cannabis patches
• Sublingual cannabis delivery
• Cannabis product manufacturing
• Nano-encapsulation technology
• Cannabis wellness products

Headquarters

HQ city

Amesbury

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Cannabis Product Sales: Revenue generated from the sale of transdermal patches (Manna Patch) and sublingual tablets (SpeedTabs) containing THC, CBD, and CBN. Products are sold through licensed dispensaries and eventually direct-to-consumer online.
2. Future Direct-to-Consumer Online Sales: The company is preparing to launch online sales of CBD and CBN products, including new forms and effects for cannabis enjoyment.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Manna Molecular develops and sells branded cannabis and CBD consumer products built around proprietary transdermal and sublingual delivery technologies. Its core offerings are the Manna Patch (a transdermal cannabis patch delivering 8-10 hours of extended-release dosing), Manna SpeedTabs (sublingual tablets with a 3-5 minute onset and 60-minute offset), and Vella, a cannabinoid-based sexual wellness serum that leverages the company's nano-encapsulation platform to target smooth muscle.

Product overview

Manna Molecular develops safe and reliable cannabis products with scientific rigor and proven technologies. The company's product portfolio consists of two main transdermal/cannabis delivery products: Manna Patch (a transdermal cannabis delivery patch that provides extended-release dosing over 8-10 hours) and Manna SpeedTabs (a sublingual tablet with rapid 3-5 minute onset). The company also offers Vella (at vellabio.com), a cannabinoid-based sexual serum for women's sexual health. All products utilize proprietary delivery technologies including nano-encapsulation for enhanced bioavailability.

Differentiator

Problem solved

Functional benefit

Brands

• Vella: A cannabinoid-based sexual serum designed for female arousal, utilizing nano-encapsulated cannabinoids to target vaginal smooth muscle.
• Manna Patch
• Manna SpeedTabs
• BevPow

Products and services

• Manna Patch A transdermal cannabis patch that delivers THC and CBD into the bloodstream through the skin for maximum bioavailability. Provides a discreet, precisely dosed, extended release of 8-10 hours with onset of 30-90 minutes. Allergen- and latex-free. Sold through licensed dispensaries to medical and recreational cannabis consumers seeking long-duration dosing without inhalation or edibles.
• Manna SpeedTabs A proprietary sublingual tablet that dissolves under the tongue to rapidly deliver cannabinoids into the bloodstream. Delivers a precise 5mg dose per tablet with onset in 3-5 minutes and offset in 60 minutes. Zero calories, gluten-free, and vegan, with 20 doses per unit. Targeted at cannabis consumers seeking fast, predictable, smoke-free dosing.
• Vella A cannabinoid-based sexual serum that uses nano-encapsulated CBD delivered to vaginal smooth muscle for relaxation effects. Developed for women's sexual health and arousal, supported by testing on the pharmacologic effects of CBD on vaginal smooth muscle in rats and humans. Sold through vellabio.com rather than dispensary channels.

Quantifiable outcome

• Onset in 3-5 minutes for sublingual products
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• VellacoreOthersVella is Manna's cannabinoid-based sexual serum brand focused on women's sexual health. The product underwent months of testing on the pharmacologic effects of CBD on vaginal smooth muscle in rats and humans. Vella is positioned at the intersection of #femtech, #sextech and women's health, with a separate website at vellabio.com.

Scale indicators1 record

Recent moves1 record

Expansion highlights5 records

Direct peers

• Papa & Barkley: Papa & Barkley is a California-based cannabis wellness brand with a strong transdermal patch and topical product line, overlapping with Manna's patch-led portfolio and its medical/recreational wellness positioning.
• Mary's Medicinals: Mary's Medicinals is best known for its transdermal cannabis patches and topical delivery formats, making it the closest direct competitor to Manna's Manna Patch in both product category and delivery mechanism.
• Foria Wellness: Foria is a cannabinoid-based sexual and intimate wellness brand, the most direct comparable to Manna's Vella sub-brand in product category (CBD sexual wellness), target consumer (women), and science-led positioning.
• Pure Ratios: Pure Ratios develops cannabis-infused transdermal patches and topicals with a science-led positioning, directly comparable to Manna's transdermal delivery approach and emphasis on precise dosing.
• LEVEL (Level Blends): LEVEL produces sublingual cannabis tablets with precise dosing and rapid onset, directly comparable to Manna's SpeedTabs in delivery format and value proposition around predictability and discretion.

Emerging players

• Kiva Confections: Kiva is a science-led cannabis edibles manufacturer with a portfolio of precisely-dosed products (gummies, mints, tablets), comparable to Manna in its science-rigor positioning and emphasis on consistent dosing.
• Cann: Cann is a leading cannabis-infused beverage brand, directly comparable to Manna's BevPow drink mix in development in terms of the cannabis beverage category and nano-emulsification delivery technology.

Broad incumbents

• Cresco Labs: Cresco Labs operates a multi-state cannabis portfolio with branded product lines including edibles and topicals; comparable to Manna as a science-positioned operator competing for the same dispensary channel.
• Curaleaf: Curaleaf is one of the largest U.S. multi-state cannabis operators with broad product portfolios including patches and beverages; it competes with Manna for dispensary shelf space across multiple of the same states.
• Tilray Brands: Tilray is a global cannabis company with diversified product lines across medical, wellness, and edibles/beverages; it represents a broad incumbent that could leverage scale to compete with Manna in alternative delivery formats.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/mannamolecular
• Xx.com/mannamolecular

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Manna Molecular